Can We Miss Pigmented Lesions in Psoriasis Patients?

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
PsoriasisMelanomaNon-melanoma Skin Cancer
Interventions
DRUG

etanercept

Patients will receive six months of treatment with Enbrel 50mg SQ given twice a week for the first three months and 50 mg once a week thereafter.

Trial Locations (1)

35233

UAB Dermatology, Birmingham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT01053819 - Can We Miss Pigmented Lesions in Psoriasis Patients? | Biotech Hunter | Biotech Hunter